Small caps: IndigoVision, Silence Therapeutics, Air Partner...

31st Jul 2012 11:51

Air Partner, a provider of air charter services, has said underlying profit before tax for the year is expected to meet its forecasts. The firm's cost reduction programme is also now nearly complete and will realise 'significant cost savings' in the next financial year, with a one off restructuring cost reported in the current year. IndigoVision has said turnover for the year ended July 31st is not expected to be less than £30m, with sales growth in the second half year expected to exceed 10% putting full year sales around 5% ahead of the previous year. Margins have improved compared with the previous year and costs have been well controlled, the Internet video security firm said. Operating profits are expected to not be less than £2.6m, more than double last year's total. Silence Therapeutics said just under half of the shares it made available via open offer were taken up, raising £5.45m for the company.Provexis, a business that develops, licenses and markets scientifically-proven functional food and sports nutrition technologies, nearly doubled it losses to £4.3m (2011: £2.3m) despite posting soaring revenues for the year ended March 31st at £3.48m (2011: £0.05m). The firm was hit by amortisation and impairment charges totalling £1.39m and burgeoning administrative costs of £5.3m (2011: £1.3m). Basic losses per share were 0.28p compared to 0.17p the previous year. Cash at the end of the year fell from £7.55m to £1.45m year-on-year.HaiKe Chemical Group, a petrochemical, speciality chemical and biochemical business, has reported slight turnover growth in the first half compared to the same period the previous year, mainly driven by a price increase in the refinery division, which itself made a gross profit, but a net loss. Both speciality and salt chemicals recorded volume increases, however prices have fallen as a result of a sluggish domestic economy. The group gross margin fell from 4.6% to 1.1% year-on-year. "Our main priorities will be to generate further cost savings and stabilise our earnings by streamlining our operations and improving internal synergies," the firm said.Allocate Software, a software provider, has acquired RealTime Health, which offers software that optimises the use of beds in hospitals, tracking a patient's progress towards a planned discharge date, for an initial cash consideration of £1.2m. The maximum total consideration, based on zero net assets, of up to £7.2m is structured as an initial payment of £1.2m and an earn-out of up to £6.0m in tranches. RealTime Health, which employs 13 staff, reported c.£0.7m in billings for the year ended December 31st 2011. In the six months to June 30th it revealed a further £0.6m of billings. Construction services company ISG has secured phase one of a significant urban regeneration project with Genesis Housing Association to deliver a mixed-use development in Ipswich. The £15m contract focuses on the delivery of 386 new homes in the town's historic docklands area and ISG is now working towards the design and costing of the full mixed-use scheme, valued at around £36m. NR